Potential Rett syndrome drug shows promising results in phase 3 trial
A potential first-of-its-kind drug to treat the symptoms of Rett syndrome received positive top-line results from a phase 3 trial sponsored by Acadia Pharmaceuticals, Inc., and led by investigators from Vanderbilt University Medical Center and the…
Read more